$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

$cpsh Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000143774924024434 Filed on August 02, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$4.247M	$5.030M
YoY Change	-42.75%	-29.15%
Cost Of Revenue	$4.771M	$5.260M
YoY Change	-8.64%	8.34%
Gross Profit	-$523.4K	-$230.0K
YoY Change	-123.83%	-110.25%
Gross Profit Margin	-12.32%	-4.57%
Selling, General & Admin	$963.1K	$1.085M
YoY Change	-34.28%	-30.02%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$131.7K	$136.5K
YoY Change	2.64%	9.58%
% of Gross Profit
Operating Expenses	$963.1K	$1.085M
YoY Change	-34.28%	-30.02%
Operating Profit	-$1.486M	-$1.315M
YoY Change	-303.38%	-289.43%
Interest Expense	$71.65K	$90.85K
YoY Change	-5368.38%	-5999.35%
% of Operating Profit
Other Income/Expense, Net	-$676.00
YoY Change	-100.83%
Pretax Income	-$1.416M	-$1.224M
YoY Change	-274.63%	-272.47%
Income Tax	-$372.7K	-$269.8K
% Of Pretax Income
Net Earnings	-$1.043M	-$954.3K
YoY Change	-273.66%	-307.82%
Net Earnings / Revenue	-24.55%	-18.97%
Basic Earnings Per Share	-$0.07	-$0.07
Diluted Earnings Per Share	-$0.07	-$0.07
COMMON SHARES
Basic Shares Outstanding	14.53M	14.52M
Diluted Shares Outstanding	14.53M	14.52M

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$5.693M	$7.056M
YoY Change	-34.43%	-4.26%
Cash & Equivalents	$4.689M	$6.306M
Short-Term Investments	$1.004M	$750.0K
Other Short-Term Assets	$506.1K	$366.7K
YoY Change	75.54%	22.38%
Inventory	$4.433M	$4.122M
Prepaid Expenses
Receivables	$3.655M	$4.064M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$14.67M	$15.82M
YoY Change	-22.53%	-11.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.082M	$2.134M
YoY Change	38.12%	54.75%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$2.250M	$1.877M
YoY Change	35.21%	1.86%
Total Long-Term Assets	$4.556M	$4.272M
YoY Change	27.57%	16.89%
TOTAL ASSETS
Total Short-Term Assets	$14.67M	$15.82M
Total Long-Term Assets	$4.556M	$4.272M
Total Assets	$19.22M	$20.09M
YoY Change	-14.58%	-6.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.497M	$2.588M
YoY Change	5.83%	26.43%
Accrued Expenses	$840.8K	$671.9K
YoY Change	-2.41%	-8.15%
Deferred Revenue	$160.4K	$65.58K
YoY Change	-91.23%	-96.41%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$20.10K	$31.89K
YoY Change	-64.54%	-28.21%
Total Short-Term Liabilities	$3.678M	$3.517M
YoY Change	-30.12%	-26.84%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Other Long-Term Liabilities	$95.28K	$132.3K
YoY Change	-65.13%	-52.07%
Total Long-Term Liabilities	$95.28K	$132.3K
YoY Change	-67.56%	-58.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.678M	$3.517M
Total Long-Term Liabilities	$95.28K	$132.3K
Total Liabilities	$3.774M	$3.649M
YoY Change	-32.1%	-28.82%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.90M	-$23.85M
YoY Change	7.93%	0.79%
Common Stock	$146.6K	$146.0K
YoY Change	0.79%	0.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$340.1K	$250.1K
YoY Change
Treasury Stock Shares
Shareholders Equity	$15.45M	$16.44M
YoY Change
Total Liabilities & Shareholders Equity	$19.22M	$20.09M
YoY Change	-14.58%	-6.27%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$1.043M	-$954.3K
YoY Change	-273.66%	-307.82%
Depreciation, Depletion And Amortization	$131.7K	$136.5K
YoY Change	2.64%	9.58%
Cash From Operating Activities	-$1.187M	-$1.048M
YoY Change	-176.34%	45.68%
INVESTING ACTIVITIES
Capital Expenditures	$80.15K	$552.4K
YoY Change	-68.81%	212.75%
Acquisitions
YoY Change
Other Investing Activities	-$253.5K	-$750.0K
YoY Change
Cash From Investing Activities	-$333.7K	-$1.302M
YoY Change	29.85%	637.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-11.78K	-11.59K
YoY Change	-188.04%	865.03%
NET CHANGE
Cash From Operating Activities	-1.187M	-1.048M
Cash From Investing Activities	-333.7K	-1.302M
Cash From Financing Activities	-11.78K	-11.59K
Net Change In Cash	-1.533M	-2.361M
YoY Change	-216.86%	163.3%
FREE CASH FLOW
Cash From Operating Activities	-$1.187M	-$1.048M
Capital Expenditures	$80.15K	$552.4K
Free Cash Flow	-$1.267M	-$1.600M
YoY Change	-197.63%	78.62%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000814676
	dei	Entity Registrant Name EntityRegistrantName	CPS TECHNOLOGIES CORP/DE/
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-28
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14601487
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14601487
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14519215
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14519215
CY2024Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	82272
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	82272
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-403284	usd
CY2024Q2	us-gaap	Marketable Securities MarketableSecurities	750000	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	8701	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	758701	usd
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2024Q2	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	0
	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-29
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-16088
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-2832509
	dei	Entity Address Address Line1 EntityAddressAddressLine1	111 South Worcester Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	Norton
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02766-2102
	dei	City Area Code CityAreaCode	508
	dei	Local Phone Number LocalPhoneNumber	222-0614
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
	dei	Trading Symbol TradingSymbol	CPSH
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14525960
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6306244	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8813626	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	758701	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4064293	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4389155	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	198348	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	83191	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4121678	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4581930	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	366655	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	276349	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	15815919	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18144251	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	9940480	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	11271982	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	891921	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	952883	usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	873730	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	985649	usd
CY2024Q2	cpsh	Property Plant And Equipment Gross Excluding Construction In Progress PropertyPlantAndEquipmentGrossExcludingConstructionInProgress	11706131	usd
CY2023Q4	cpsh	Property Plant And Equipment Gross Excluding Construction In Progress PropertyPlantAndEquipmentGrossExcludingConstructionInProgress	13210514	usd
CY2024Q2	cpsh	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Construction In Progress AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingConstructionInProgress	10068557	usd
CY2023Q4	cpsh	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Construction In Progress AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingConstructionInProgress	11936004	usd
CY2024Q2	cpsh	Construction In Progress Net ConstructionInProgressNet	496331	usd
CY2023Q4	cpsh	Construction In Progress Net ConstructionInProgressNet	281629	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2133905	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1556139	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	261000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	332000	usd
CY2024Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1877302	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	1569726	usd
CY2024Q2	us-gaap	Assets Assets	20088126	usd
CY2023Q4	us-gaap	Assets Assets	21602116	usd
CY2024Q2	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	31885	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	46797	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2587874	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2535086	usd
CY2024Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	671853	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1075137	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	65578	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	251755	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3517190	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4068775	usd
CY2024Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	0	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	8090	usd
CY2024Q2	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31277	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	31277	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	101000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	172000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	3649467	usd
CY2023Q4	us-gaap	Liabilities Liabilities	4280142	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	146015	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	146015	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40386335	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	40180893	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	8701	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23852254	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-22754796	usd
CY2024Q2	us-gaap	Treasury Stock Value TreasuryStockValue	250138	usd
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	250138	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	16438659	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17321974	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20088126	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21602116	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5030313	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7418138	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	10942947	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	14518405	usd
CY2024Q2	us-gaap	Revenues Revenues	5030313	usd
CY2023Q3	us-gaap	Revenues Revenues	7418138	usd
	us-gaap	Revenues Revenues	10942947	usd
	us-gaap	Revenues Revenues	14518405	usd
CY2024Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5260305	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5221879	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10266629	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	10077444	usd
CY2024Q2	us-gaap	Gross Profit GrossProfit	-229992	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	2196259	usd
	us-gaap	Gross Profit GrossProfit	676318	usd
	us-gaap	Gross Profit GrossProfit	4440961	usd
CY2024Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1084995	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1465349	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2250917	usd
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	3015871	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1314987	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	730910	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1574599	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	1425090	usd
CY2024Q2	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	90851	usd
CY2023Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	79652	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	170021	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	95242	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1224136	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	810562	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1404578	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1520332	usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-269832	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	210058	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-307120	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	460628	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-954304	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	600503	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1097458	usd
	us-gaap	Net Income Loss NetIncomeLoss	1059704	usd
CY2024Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	8701	usd
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	8701	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8701	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8701	usd
CY2024Q2	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-945603	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	600503	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1088757	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1059704	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14493970
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14473128
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14621929
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14519215
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14630765
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	17339782	usd
CY2024Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	44480	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8701	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-954304	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	16438659	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	17321974	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	205442	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	8701	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1097458	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	16438659	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	16304653	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17316	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	24120	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	600503	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	16946592	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	15705516	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	147757	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	33615	usd
	us-gaap	Net Income Loss NetIncomeLoss	1059704	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	16946592	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1097458	usd
	us-gaap	Net Income Loss NetIncomeLoss	1059704	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	237954	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	252969	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	205442	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	147757	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-324862	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1296584	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	115157	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-611028	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-460252	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-62148	usd
	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	90306	usd
	cpsh	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	77073	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	52788	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	522667	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	40658	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	307576	usd
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-405404	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-186177	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-892803	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-918660	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	835875	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	815720	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	433579	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	750000	usd
	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	-0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1565720	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-433579	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	33615	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	23002	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	21439	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-23002	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12176	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2507382	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	414472	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8813626	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8266753	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6306244	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8681225	usd
	us-gaap	Interest Paid Net InterestPaidNet	1465	usd
	us-gaap	Interest Paid Net InterestPaidNet	2902	usd
	us-gaap	Stock Issued1 StockIssued1	0	usd
	us-gaap	Stock Issued1 StockIssued1	71090	usd
CY2024Q2	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	758701	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-954304	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	600503	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1097458	usd
	us-gaap	Net Income Loss NetIncomeLoss	1059704	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14493970
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14473128
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.07
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-954304	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	600503	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1097458	usd
	us-gaap	Net Income Loss NetIncomeLoss	1059704	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14493970
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14519215
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14473128
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q3	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	127959
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	157637
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14519215
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14621929
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14519215
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14630765
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.07
CY2024Q2	us-gaap	Area Of Real Estate Property AreaOfRealEstateProperty	38000
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	83000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	165000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	28000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	276000	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	15000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	261000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	160000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	101000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	261000	usd
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P20M
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.066	pure
CY2024Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
CY2023Q3	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	79000
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	86001
CY2023Q3	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.2
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.22
CY2023Q3	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	24642
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	24927
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1097900
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M21D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	610000
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.45
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y1M2D
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	1500000
CY2024Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	648	usd
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y11M4D
CY2024Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	44480	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	205442	usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	17316	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Compensation Cost1 SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1	147757	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2567758	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2861333	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1579991	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1493582	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	393889	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	537975	usd
CY2024Q2	us-gaap	Inventory Gross InventoryGross	4541638	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	4892890	usd
CY2024Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	419960	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	310960	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4121678	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4581930	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	67846	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	86000	usd
CY2024Q2	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	246953	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	649201	usd
CY2024Q2	cpsh	Accrued Product Returns AccruedProductReturns	288000	usd
CY2023Q4	cpsh	Accrued Product Returns AccruedProductReturns	288000	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	69054	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	51936	usd
CY2024Q2	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	671853	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1075137	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	23795	usd
CY2024Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	8090	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	31885	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1465	usd
CY2024Q2	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	40256	usd
	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	307576	usd

Files In Submission

Name	View Source	Status
0001437749-24-024434-index-headers.html	Edgar Link	pending
0001437749-24-024434-index.html	Edgar Link	pending
0001437749-24-024434.txt	Edgar Link	pending
0001437749-24-024434-xbrl.zip	Edgar Link	pending
cpsh-20240629.xsd	Edgar Link	pending
cpsh20240629_10q.htm	Edgar Link	pending
ex_706824.htm	Edgar Link	pending
ex_706825.htm	Edgar Link	pending
ex_706826.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
cpsh20240629_10q_htm.xml	Edgar Link	completed
cpsh-20240629_def.xml	Edgar Link	unprocessable
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cpsh-20240629_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
cpsh-20240629_pre.xml	Edgar Link	unprocessable
cpsh-20240629_lab.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2024 Q3 Form 10-Q Financial Statement

#000143774924024434 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH CPS TECHNOLOGIES CORP/DE/ Stock $cpsh

2024 Q3 Form 10-Q Financial Statement

#000143774924024434 Filed on August 02, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CPSH
CPS TECHNOLOGIES CORP/DE/ Stock $cpsh